Last edition
News about
The U.S. Food and Drug Administration and the National Telecommunications and Information Administration (NTIA) are launching a 120-day pilot to help reduce the availability of unapproved opioids illegally offered for sale online
India announces collaboration with Australia for Covid-19
Prime Minister Narendra Modi and the Prime Minister of Australia, Scott Morrison MP, announced a COVID-19 collaboration in 2020 during an India-Australia leaders' virtual summit held on June 4, 2020
NPPA issues list of revised MRPs to ensure compliance on price of N- 95 mask
To ensure the availability of N-95 masks at the revised MRPs as per price control compliance, the National Pharmaceutical Pricing Authority (NPPA) has issued a list of price reduction in N-95 masks by four major N-95 mask manufacturers, namely Venus Safety and Health Pvt Ltd, Magnum Health and Safety, Yash Care Life Sciences and Joseph Leslie & Co
Lupin: U.S. FDA Grants Mexiletine Orphan Drug Designation
Pharma major Lupin Limited (Lupin) is announced today that the US Food and Drug Administration (U.S. FDA) has granted Orphan Drug Designation (ODD) to mexiletine hydrochloride for the treatment of myotonic disorders
FDA Publicly Shares Antibody Test Performance Data From Kits as Part of Validation Study
Today, the U.S. Food and Drug Administration publicly posted test performance data from four more antibody, or serology, test kits on open.fda.gov from its independent performance validation study effort with the National Institutes of Health's (NIH) National Cancer Institute (NCI)
The COVID19 pandemic has so far affected 216 countries and caused more than 59.31 lakh cases and 3.65 lakh deaths worldwide
Websites facilitating E-pharmacy apps get de-linked from Arogya Setu app
The Central government has told the Delhi High Court that it has delinked Aarogya Setu app from the website facilitating e-pharmacy operation
These data confirm the longer-term efficacy of Alecensa already demonstrated across three phase III clinical trials. Full findings were presented at the ASCO20 Virtual Scientific Programme, on 29 May 2020
FDA Takes Steps to Streamline Development of Tests With At-Home Sample Collection
Today the U.S. Food and Drug Administration took steps to further support the development of COVID-19 tests for at-home self-collection by including a voluntary EUA template for at-home sample collection kits to its website
Merck and Ridgeback Biotherapeutics LP, a closely held biotechnology company, announced that the companies have entered into a collaboration agreement to develop EIDD-2801, an orally available antiviral candidate currently in early clinical development for the treatment of patients with COVID-19
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy